In mice fed a high-fat diet (HFD), combined gene therapy with FGF21 and sTGFBR2 effectively mitigated 4 age-related diseases: obesity, type 2 diabetes, heart failure, and renal failure (23). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.